Unique ID issued by UMIN | UMIN000049491 |
---|---|
Receipt number | R000056356 |
Scientific Title | Test of suppression of postprandial blood glucose elevation by food ingestion |
Date of disclosure of the study information | 2023/10/31 |
Last modified on | 2023/03/02 17:08:05 |
Test of suppression of postprandial blood glucose elevation by food ingestion
Test of suppression of postprandial blood glucose elevation by food ingestion
Test of suppression of postprandial blood glucose elevation by food ingestion
Test of suppression of postprandial blood glucose elevation by food ingestion
Japan |
Healthy Adults
Adult |
Others
NO
To examine the inhibitory effect of test foods on postprandial blood glucose elevation
Efficacy
Changes in postprandial blood glucose levels
Interventional
Cross-over
Randomized
Cluster
Double blind -all involved are blinded
Placebo
2
Treatment
Food |
Single intake of test foods containing bitter gourd, etc.
Single intake of placebo foods
20 | years-old | <= |
60 | years-old | > |
Male and Female
(1) Male and female subjects aged 20 to 64 years (2) Normal to slightly elevated fasting blood glucose level (125 mg/dL or less) at baseline (3) Subjects who give written voluntary consent to participate in the study
(1) Persons who are currently judged to have and treated diabetes mellitus (2) Persons who are currently receiving medication for diabetes mellitus or hypertension (3) Persons who are consuming foods or health foods containing ingredients of this experimental food (4) Persons who are regularly taking supplements related to cholesterol, blood pressure, blood lipids, blood sugar levels (5) Persons who have serious diseases related to sugar metabolism, lipid metabolism (6) Persons with serious diseases or mental disorders of liver function, renal function, heart, circulatory system, respiratory system, endocrine system, immune system, nervous system (6) Subjects with a history of abnormal laboratory values and judged to have problems in participating in the study (7) Subjects with a disease under treatment or a history of a serious disease requiring medication (8) Subjects at risk of developing allergies related to the study (9) Subjects who are not suitable as subjects based on the results of the Lifestyle Questionnaire. (10) Subjects who are participating in other clinical studies at the start of this study (11) Subjects who are pregnant or plan to become pregnant or breastfeeding during the study period (12) Subjects who are judged by the investigator (or the study administrator) to be unsuitable for study participation
20
1st name | Ryuji |
Middle name | |
Last name | Takeda |
Kansai University of Welfare Sciences
Department of Nutritional Sciences for Welll-being Faculty of Health Science for Welfare
582-0026
Kashiwara-cuty
072-978-0088
rtakeda@tamateyama.ac.jp
1st name | Shigefumi |
Middle name | |
Last name | Nibun |
EAS inc.
Clinical Trial Session
236-0028
Susaki-Cho1-10-2F, Kanazawa-ku, Yokohama city, Kanagawa
070-5415-3051
info@eas-ct.jp
Lifix Corporation
Lifix Corporation
Profit organization
KOBUNA ORTHOPEDIC SURGERY
311-2, Gokan-machi, Maebashi, Gunma
027-261-7600
info@kobunaseikei.jp
NO
横浜みのるクリニック(神奈川県)
2023 | Year | 10 | Month | 31 | Day |
Unpublished
Completed
2022 | Year | 09 | Month | 25 | Day |
2022 | Year | 09 | Month | 29 | Day |
2022 | Year | 11 | Month | 15 | Day |
2022 | Year | 12 | Month | 25 | Day |
2022 | Year | 11 | Month | 13 | Day |
2023 | Year | 03 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056356